Gal-3 has been shown to affect multiple processes in the tumor microenvironment (TME), such as promoting tumor invasion, migration, and angiogenesis (6), and has immunosuppressive effects due to promoting M2 macrophage activation and inhibiting T cell function (7–9). This evidence concerns the gene LGALS3 and neoplasm.